Department of Nephrology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China.
Dialysis Department of Nephrology Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
J Int Med Res. 2021 Oct;49(10):3000605211053276. doi: 10.1177/03000605211053276.
Chronic kidney disease (CKD) is a serious non-communicable disease that poses a significant burden on healthcare and society. It is essential to devise new strategies to better treat patients with CKD. Research has illustrated that gut dysbiosis, describing an abnormal intestinal ecology, is closely associated with CKD. In this narrative review, we summarized the evidence of their mutual relationship and discussed the potential treatment options to correct gut dysbiosis in patients with CKD. Gut dysbiosis significantly increases the risk of CKD, especially in the older population. Gut dysbiosis also plays a role in CKD complications, such as hypertension, cardiovascular events, and cognitive dysfunction. The relationship between gut dysbiosis and CKD is bidirectional, and CKD itself can lead to changes in gut microecology. The usual therapies for CKD can also increase the incidence of gut dysbiosis. Meanwhile, probiotics and antibiotics are generally used to correct gut dysbiosis. Further studies are required to elaborate the association between gut dysbiosis and CKD, and more treatment options should be explored to prevent CKD in patients with gut dysbiosis.
慢性肾脏病(CKD)是一种严重的非传染性疾病,给医疗保健和社会带来了重大负担。制定新的策略来更好地治疗 CKD 患者至关重要。研究表明,肠道菌群失调,描述一种异常的肠道生态,与 CKD 密切相关。在这篇叙述性综述中,我们总结了它们相互关系的证据,并讨论了纠正 CKD 患者肠道菌群失调的潜在治疗选择。肠道菌群失调显著增加了 CKD 的风险,尤其是在老年人群中。肠道菌群失调也在 CKD 并发症中发挥作用,如高血压、心血管事件和认知功能障碍。肠道菌群失调与 CKD 之间的关系是双向的,CKD 本身可导致肠道微生态的变化。用于治疗 CKD 的常规疗法也会增加肠道菌群失调的发生率。同时,益生菌和抗生素通常用于纠正肠道菌群失调。需要进一步研究来阐述肠道菌群失调与 CKD 之间的关联,并探索更多的治疗选择,以预防肠道菌群失调患者的 CKD。